Litigation Details for Takeda Pharmaceutical Company Limited v. Norwich Pharmaceuticals, Inc. (D. Del. 2020)
✉ Email this page to a colleague
Takeda Pharmaceutical Company Limited v. Norwich Pharmaceuticals, Inc. (D. Del. 2020)
| Docket | ⤷ Start Trial | Date Filed | 2020-07-16 |
| Court | District Court, D. Delaware | Date Terminated | 2020-10-30 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Patents | 7,105,486; 7,223,735; 7,655,630; 7,659,253; 7,659,254; 7,662,787; 7,662,788; 7,671,030; 7,671,031; 7,674,774; 7,678,770; 7,678,771; 7,687,466; 7,687,467; 7,700,561; 7,713,936; 7,718,619; 7,723,305 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Takeda Pharmaceutical Company Limited v. Norwich Pharmaceuticals, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Start Trial .
Biologic Drugs cited in Takeda Pharmaceutical Company Limited v. Norwich Pharmaceuticals, Inc.
The biologic drug covered by the patents cited in this case is ⤷ Start Trial .
Details for Takeda Pharmaceutical Company Limited v. Norwich Pharmaceuticals, Inc. (D. Del. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-07-16 | External link to document | |||
| 2020-07-16 | 1 | Complaint | Code, involving United States Patent No. 7,105,486 (“the ’486 patent”) (attached as Exhibit A hereto…States Patent No. 7,662,788 (“the ’788 patent”) (attached as Exhibit G hereto); United States Patent No.…030 patent”) (attached as Exhibit H hereto); United States Patent No. 7,671,031 (“the ’031 patent”) …States Patent No. 7,674,774 (“the ’774 patent”) (attached as Exhibit J hereto); United States Patent No.…770 patent”) (attached as Exhibit K hereto); United States Patent No. 7,678,771 (“the ’771 patent”) | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
